In basal-like TN breast cancer, CCL20 promotes bone metastasis by raising the secretion of MMP-2/9 and increasing the receptor activator of nuclear factors-kappa B (NF-κB) ligand/osteoprotegerin ratio in breast cancer and osteoblastic cells (108). Here, MMP2 is linked to breast cancer.